Your browser doesn't support javascript.
loading
Overcoming sunitinib resistance with tocilizumab in renal cell carcinoma: Discordance between in vitro and in vivo effects.
Kamli, Hossam; Owens, Evan P; Vesey, David A; Prasanna, Rajagopalan; Li, Li; Gobe, Glenda C; Morais, Christudas.
Afiliação
  • Kamli H; Centre for Kidney Disease Research, The University of Queensland, Translational Research Institute, Brisbane, Australia; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
  • Owens EP; Centre for Kidney Disease Research, The University of Queensland, Translational Research Institute, Brisbane, Australia.
  • Vesey DA; Centre for Kidney Disease Research, The University of Queensland, Translational Research Institute, Brisbane, Australia; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.
  • Prasanna R; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
  • Li L; Institute for Translational Research, Ochsner Clinical School, University Queensland School of Medicine, Ochsner Clinic Foundation, New Orleans, LA, USA.
  • Gobe GC; Centre for Kidney Disease Research, The University of Queensland, Translational Research Institute, Brisbane, Australia. Electronic address: g.gobe@uq.edu.au.
  • Morais C; Department of Urology, Princess Alexandra Hospital, Brisbane, Australia; School of Biomedical Sciences, The University of Queensland, Brisbane, Australia. Electronic address: Christudas.Morais@health.qld.gov.au.
Biochem Biophys Res Commun ; 586: 42-48, 2022 01 01.
Article em En | MEDLINE | ID: mdl-34826699
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Resistencia a Medicamentos Antineoplásicos / Anticorpos Monoclonais Humanizados / Sunitinibe / Neoplasias Renais / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Resistencia a Medicamentos Antineoplásicos / Anticorpos Monoclonais Humanizados / Sunitinibe / Neoplasias Renais / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article